CRISPR Archives

HEADLINES

[ October 5, 2025 ] Don’t Rule Out The Return Of US Troops To Bagram Airbase Geopolitical
[ October 4, 2025 ] BlackRock’s GIP Wins Approval of $6 Billion Allete Deal – How investors look at the deal AI
[ October 4, 2025 ] Wall Street Found Big Oil. Who Would Have Thought? – ENB Weekly Recap AI
[ October 4, 2025 ] Update on the Chevron Refinery in California – A national security disaster just got worse as a possible drone strike Crude Oil News
[ October 4, 2025 ] AI Computing Demand: An Additional 55 GW of Power Capacity Required Globally by 2030 Electrical Generation / Utilities
[ October 4, 2025 ] AI Demand and Grid Upgrades Drive Fresh Copper Boom – What companies are potential good investments? Critical Minerals
[ October 4, 2025 ] OPEC+: Reuters Leaks on Oil Plans Again – But can they deliver? Crude Oil News
[ October 4, 2025 ] Shadow tanker accused of being Europe’s drone mothership Crude Oil News
[ October 3, 2025 ] Net-Zero Banking Alliance Folds After Mass Exodus by Members Big Oil Companies
[ October 3, 2025 ] Burgum, Zeldin, Wright: This is how America Achives Energy Dominance CO2 & GHG

CRISPR Therapeutics Stock Sees Relative Strength Rating Rise To 89

May 10, 2023 Mariel Alumit

One important metric to look for in a stock is an 80 or higher Relative Strength Rating. CRISPR Therapeutics (CRSP) cleared that benchmark Wednesday, with a jump from 69 to 89 Wednesday. When looking for […]

Verification: 7f1ceb4b4b21970d